Cargando…

Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases

In this mini-review, we highlight selected research by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence “Precision Medicine in Chronic Inflammation” focusing on clinical sequencing and the clinical utility of polygenic risk scores as well as its implication on precision medicine in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hübenthal, Matthias, Löscher, Britt-Sabina, Erdmann, Jeanette, Franke, Andre, Gola, Damian, König, Inke R., Emmert, Hila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901950/ https://www.ncbi.nlm.nih.gov/pubmed/33633722 http://dx.doi.org/10.3389/fimmu.2020.577677

Ejemplares similares

Clinical utility of polygenic scores for cardiometabolic disease in Arabs
por: Shim, Injeong, et al.
Publicado: (2023)

Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology
por: Qassim, Ayub, et al.
Publicado: (2021)

The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021)

Clinical utility of polygenic risk scores: a critical 2023 appraisal
por: Koch, Sebastian, et al.
Publicado: (2023)

Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
por: Koch, Sebastian, et al.
Publicado: (2021)

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization
por: Lewis, Anna C. F., et al.
Publicado: (2022)

Identification of interactions using model-based multifactor dimensionality reduction
por: Gola, Damian, et al.
Publicado: (2016)

Empowering individual trait prediction using interactions for precision medicine
por: Gola, Damian, et al.
Publicado: (2021)

The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2023)

On the utilization of polygenic risk scores for therapeutic targeting
por: Gibson, Greg
Publicado: (2019)

The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review
por: Kumuthini, Judit, et al.
Publicado: (2022)

A survey of genome-wide association studies, polygenic scores and UK Biobank highlights resources for autoimmune disease genetics
por: Saurabh, Rochi, et al.
Publicado: (2022)

Post‐GWAS Polygenic Risk Score: Utility and Challenges
por: Nguyen, Tuan V, et al.
Publicado: (2020)

Assessment of Imputation Quality: Comparison of Phasing and Imputation Algorithms in Real Data
por: Stahl, Katharina, et al.
Publicado: (2021)

Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021)

Will polygenic risk scores for cancer ever be clinically useful?
por: Sud, Amit, et al.
Publicado: (2021)

Applicability of polygenic risk scores in endometriosis clinical presentation
por: Svensson, Agnes, et al.
Publicado: (2022)

The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
por: Cupido, Arjen J., et al.
Publicado: (2021)

Cognitive Decline in Alzheimer’s Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting
por: Euesden, Jack, et al.
Publicado: (2020)

Genome interpretation in a federated learning context allows the multi-center exome-based risk prediction of Crohn’s disease patients
por: Raimondi, Daniele, et al.
Publicado: (2023)

Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
por: Palk, A. C., et al.
Publicado: (2019)

Polygenic risk scores: from research tools to clinical instruments
por: Lewis, Cathryn M., et al.
Publicado: (2020)

The potential of polygenic scores to improve cost and efficiency of clinical trials
por: Fahed, Akl C., et al.
Publicado: (2022)

Are polygenic risk scores ready for the cancer clinic?—a perspective
por: Klein, Robert J., et al.
Publicado: (2022)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Association Between Psychiatric Polygenic Scores, Healthcare Utilization and Comorbidity Burden
por: Kirchner, H. Lester, et al.
Publicado: (2023)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

Polygenic risk scores and their potential clinical use in psychiatry: are we there yet?
por: Fries, Gabriel R.
Publicado: (2020)

Polygenic risk scores in schizophrenia with clinically significant copy number variants
por: Taniguchi, Satoru, et al.
Publicado: (2019)

Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
por: Zhou, Xiaopu, et al.
Publicado: (2021)

Development of a clinical polygenic risk score assay and reporting workflow
por: Hao, Limin, et al.
Publicado: (2022)

Idéfix: identifying accidental sample mix-ups in biobanks using polygenic scores
por: Warmerdam, Robert, et al.
Publicado: (2021)

Commentary: Polygenic risk for breast cancer: in search for potential clinical utility
por: Wang, Tingting, et al.
Publicado: (2021)

Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
por: Baker, Emily, et al.
Publicado: (2020)

Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences
por: Rosenberg, Noah A, et al.
Publicado: (2018)

Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease
por: King, Austin, et al.
Publicado: (2022)

Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score
por: Gao, Q., et al.
Publicado: (2022)

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
por: Coombes, Brandon J., et al.
Publicado: (2020)

Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues
por: Lewis, Anna C. F., et al.
Publicado: (2021)

Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease
por: Vacher, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tc0q43p9m4vbiogrvl7un6u0a5